share_log

bluebird bio | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-STATE STREET CORPORATION(1.80%)

bluebird bio | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)

bluebird bio | SC 13G/A：超过5%持股股东披露文件(修正)
SEC announcement ·  04/10 09:57
Moomoo AI 已提取核心信息
State Street Corporation has filed an amended Schedule 13G with the United States Securities and Exchange Commission (SEC) on March 31, 2024, indicating a change in its holdings of bluebird bio, Inc. common stock. The filing, categorized under Rule 13D-1(B), shows that State Street Corporation has shared voting power over 3,293,844 shares and shared dispositive power over 3,428,135 shares of bluebird bio. This represents a significant stake in the company, as the aggregate amount of shares beneficially owned by State Street Corporation constitutes more than five percent of bluebird bio's class of common stock. The filing asserts that the shares were acquired and are held in the ordinary course of business, not with the intent of changing or influencing the control of the issuer...Show More
State Street Corporation has filed an amended Schedule 13G with the United States Securities and Exchange Commission (SEC) on March 31, 2024, indicating a change in its holdings of bluebird bio, Inc. common stock. The filing, categorized under Rule 13D-1(B), shows that State Street Corporation has shared voting power over 3,293,844 shares and shared dispositive power over 3,428,135 shares of bluebird bio. This represents a significant stake in the company, as the aggregate amount of shares beneficially owned by State Street Corporation constitutes more than five percent of bluebird bio's class of common stock. The filing asserts that the shares were acquired and are held in the ordinary course of business, not with the intent of changing or influencing the control of the issuer, nor in connection with any transaction that has such purpose or effect. The subsidiaries of State Street Corporation listed in the filing as beneficial owners include SSGA Funds Management, Inc., State Street Global Advisors Europe Limited, State Street Global Advisors Limited, and State Street Global Advisors Trust Company, all classified as Investment Advisors (IA).
State Street Corporation已于2024年3月31日向美国证券交易委员会（SEC）提交了经修订的附表13G，表明其持有的蓝鸟生物公司普通股发生了变化。该文件归类于第13D-1（B）条，显示道富公司对3,293,844股股票共享投票权，对蓝鸟生物的3,428,135股股票共享处置权。这是该公司的重要股份，因为State Street Corporation实益持有的股份总额占蓝鸟生物普通股类别的5％以上。该文件称，这些股份是在正常业务过程中收购和持有的，其目的不是改变或影响发行人的控制权，也不是与任何具有此类目的或效果的交易有关。文件中列为受益所有人的道富公司的子公司包括SSGA基金管理有限公司、道富环球顾问欧洲有限公司、道富环球顾问有限公司和道富环球顾问信托公司，均被归类为投资顾问（IA）。
State Street Corporation已于2024年3月31日向美国证券交易委员会（SEC）提交了经修订的附表13G，表明其持有的蓝鸟生物公司普通股发生了变化。该文件归类于第13D-1（B）条，显示道富公司对3,293,844股股票共享投票权，对蓝鸟生物的3,428,135股股票共享处置权。这是该公司的重要股份，因为State Street Corporation实益持有的股份总额占蓝鸟生物普通股类别的5％以上。该文件称，这些股份是在正常业务过程中收购和持有的，其目的不是改变或影响发行人的控制权，也不是与任何具有此类目的或效果的交易有关。文件中列为受益所有人的道富公司的子公司包括SSGA基金管理有限公司、道富环球顾问欧洲有限公司、道富环球顾问有限公司和道富环球顾问信托公司，均被归类为投资顾问（IA）。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息